Sedation is one of the details of ICU care which seems unimportant… until it's not. Over the past decade we've seen a burgeoning repertoire of agents used for sedation and agitated delirium. Unfortunately, the number of medications has out-stripped available Level-I evidence regarding how exactly to use them. This chapter attempts to create a framework for the selection and use of various agents. Looming drug shortages due to COVID-19 may force us to push the envelope, by using different agents in ways which we haven't previously.
The IBCC chapter is located 👉 here.
- The podcast & comments are below.
Follow us on iTunes
- IBCC chapter – Disseminated Intravascular Coagulation (DIC) - January 18, 2021
- PulmCrit- RCTs don't justify using convalescent plasma or antibody cocktails - January 14, 2021
- PulmCrit – Six RCTs to answer one question: what is the role of tocilizumab in COVID-19? - January 12, 2021